Cargando…

Erectile dysfunction : causes, risk factors, and management /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Grant, Paul Steven (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Biomedical, Nova Science Publishers, Inc., [2012]
Colección:Human sexuality.
Sexology research and issues.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBSCO_ocn972010894
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |||||||||||
008 180410s2012 nyua ob 001 0 eng
010 |a  2017285162 
040 |a DLC  |b eng  |e rda  |e pn  |c DLC  |d YDX  |d YDXCP  |d N$T  |d E7B  |d EBLCP  |d DEBSZ  |d D6H  |d AGLDB  |d OCLCF  |d LVT  |d DKU  |d SNK  |d BTN  |d INTCL  |d MHW  |d AUW  |d OCLCQ  |d VNS  |d VTS  |d OCLCO  |d AU@  |d S8J  |d S9I  |d M8D  |d OCLCO  |d A6Q  |d OCLCQ  |d K6U  |d OCLCA  |d OCLCQ  |d AJS  |d OCLCO  |d OCLCQ 
019 |a 828140652  |a 923653298  |a 972077327  |a 1009010894  |a 1038970890  |a 1058906962  |a 1083625878  |a 1096231689  |a 1105788038 
020 |a 9781619423206  |q (eBook) 
020 |a 1619423200 
020 |a 1619423162 
020 |a 9781619423169 
020 |z 9781619423169  |q (hardcover) 
029 1 |a DEBBG  |b BV043774742 
029 1 |a DEBSZ  |b 472770934 
035 |a (OCoLC)972010894  |z (OCoLC)828140652  |z (OCoLC)923653298  |z (OCoLC)972077327  |z (OCoLC)1009010894  |z (OCoLC)1038970890  |z (OCoLC)1058906962  |z (OCoLC)1083625878  |z (OCoLC)1096231689  |z (OCoLC)1105788038 
042 |a pcc 
050 0 0 |a RC889  |b .E7525 2012 
060 4 |a WJ 709 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 0 |a 616.6/922  |2 23 
049 |a UAMI 
245 0 0 |a Erectile dysfunction :  |b causes, risk factors, and management /  |c Paul Steven Grant, editor. 
264 1 |a New York :  |b Nova Biomedical, Nova Science Publishers, Inc.,  |c [2012] 
264 4 |c Ã2012 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Human sexuality 
490 1 |a Sexology research and issues 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a ERECTILE DYSFUNCTION -- ERECTILE DYSFUNCTION -- Contents -- Foreword -- Part One -- Introduction -- References -- A Primary Care Approach to Erectile Dysfunction -- Abstract -- Introduction -- Assessment of ED -- Common Causes of Erectile Dysfunction -- Baseline Investigations -- Men in the Following Categories Require Referral -- Developing a Treatment Plan -- Phase 1: Stabilise General Clinical Condition -- Phase 2: Treat Correctable Causes -- Phase 3: Initiate Specific Therapy for Erectile Dysfunction -- Phase 4: Onward Referral 
505 8 |a Conclusion References -- Erectile Dysfunction: Causes, Risk Factors and Management -- Abstract -- Introduction -- Epidemiology -- Physiology of Erection -- Pathophysiology of Erectile Dysfunction -- Psychogenic ED -- Neurogenic ED -- Hormonal Causes of ED -- Vascular Causes of ED -- Drug-Induced Erectile Dysfunction -- Erectile Dysfunction due to other Systemic Diseases and Ageing -- Renal Disease -- Spinal Cord Injury -- Correlations of ED with CAD and DM -- Correlation of ED with Lower Urinary Tract Symptoms (LUTS) 
505 8 |a Clinical Evaluation Quantification of the Severity of Erectile Dysfunction and Improvement -- Physical Examination -- Laboratory Studies -- Special Studies -- Penile Duplex Doppler Imaging -- Management of Erectile Dysfunction -- I. Medical and other Non-surgical Treatment -- Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors) -- 1. Sildenafil Citrate (Viagra) -- 2. Vardenafil (Levitra) -- 3. Tadalafil (Cialis) -- 4. Use of PDE5 Inhibitors and Cardiovascular Safety -- Apomorphine (Uprima) -- Adrenergic-Receptor Antagonists 
505 8 |a 1. Phentolamine (Regitine) 2. Yohimbine -- Trazodone (Desyrel, Mesyrel) -- Dietary Supplements and Erectile Dysfunction -- 1. Ginkgo Bilboa -- 2. L-Arginine -- Intracavernosal and Intraurethral Therapy -- 1. Alprostadil (Prostaglandin E1, Caverject, Medicated Urethral System for Erection) -- 2. Papaverine -- 3. Phentolamine (Regitine) -- 4. Moxisylyte Chlorohydrate -- 5. Chlorpromazine (Thorazine) -- 6. Vasoactive Intestinal Polypeptide (VIP) -- Testosterone -- Vacuum Constrictive Device -- II. Surgical Treatment 
505 8 |a Penile Prostheses Implantation Penile Revascularization -- Venectomy -- III. Future Treatments -- Gene Therapy -- 1. Gene Therapy and NOS -- 2. Gene Therapy and the Human Calcium-Sensitive Potassium Channel Subtype -- 3. Gene Therapy and Vascular Endothelial Growth Factor (VEGF) and other Molecular Targets -- Conclusion -- References -- Current and Emerging Novel Diagnostic Tools for the Diagnosis of Male Erectile Dysfunction -- Abstract -- Introduction -- Consensus and Major International Guidelines on the Investigations of ED 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Impotence. 
650 1 2 |a Erectile Dysfunction 
650 6 |a Impuissance sexuelle. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Impotence.  |2 fast  |0 (OCoLC)fst00968233 
700 1 |a Grant, Paul Steven,  |e editor. 
776 0 8 |i Print version:  |t Erectile dysfunction.  |d New York : Nova Science Publishers, [2012]  |z 9781619423169  |w (DLC) 2012938162 
830 0 |a Human sexuality. 
830 0 |a Sexology research and issues. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540911  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3017697 
938 |a ebrary  |b EBRY  |n ebr10654668 
938 |a EBSCOhost  |b EBSC  |n 540911 
938 |a YBP Library Services  |b YANK  |n 7311779 
994 |a 92  |b IZTAP